Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Young Teresa L.. Insider active across 1 company, notably Seres Therapeutics, Inc.. In total, 12 reports have been published. History available since 27 October 2023. The latest transaction was disclosed on 27 October 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations
Young Teresa L. is a declarant linked to Seres Therapeutics, Inc. on XNAS, with See Remarks listed as the role. The record shows 12 filings, all within the sampled set, from 2023-10-31 to 2026-02-18, and the most common transaction nature is Option Exercise.